The E. coli Effector Protein NleF Is a Caspase Inhibitor

• Sonja Blasche,

  Affiliation Genomics and Proteomics Core Facilities, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Mario Mörtl,

  Affiliation Proteros biostructures GmbH, Martinsried, Germany

  ⨯
• Holger Steuber,

  Current address: Philipps-Universität Marburg, LOEWE-Center for Synthetic Microbiology, Marburg, Germany

  Affiliation Proteros biostructures GmbH, Martinsried, Germany

  ⨯
• Gabriella Siszler,

  Affiliation Genomics and Proteomics Core Facilities, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Shahista Nisa,

  Affiliation School of Medicine, University of Maryland, Baltimore, Maryland, United States of America

  ⨯
• Frank Schwarz,

  Affiliation Genomics and Proteomics Core Facilities, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Inna Lavrik,

  Current address: Department of Translational Inflammation Research, Institute of Experimental Internal Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany

  Affiliation Division of Immunogenetics, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Thomas M. A. Gronewold,

  Affiliation SAW Instruments GmbH, Bonn, Germany

  ⨯
• Klaus Maskos,

  Affiliation Proteros biostructures GmbH, Martinsried, Germany

  ⨯
• Michael S. Donnenberg,

  Affiliation School of Medicine, University of Maryland, Baltimore, Maryland, United States of America

  ⨯
• Dirk Ullmann,

  Current address: Evotec AG, Martinsried, Germany

  Affiliation Proteros biostructures GmbH, Martinsried, Germany

  ⨯
• Peter Uetz ,

  * E-mail: uetz@vcu.edu

  Affiliation Center for the Study of Biological Complexity, Virginia Commonwealth University, Richmond, Virginia, United States of America

  ⨯
• Manfred Kögl

  Current address: Boehringer Ingelheim, Vienna, Austria

  Affiliation Genomics and Proteomics Core Facilities, German Cancer Research Center, Heidelberg, Germany

  ⨯